SWTX - SpringWorks Therapeutics GAAP EPS of -$1.18 revenue of $21M
2024-05-02 06:36:45 ET
More on SpringWorks Therapeutics
- SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear
- SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners
- SpringWorks Therapeutics jumps amid takeover speculation
- Seeking Alpha’s Quant Rating on SpringWorks Therapeutics
- Historical earnings data for SpringWorks Therapeutics